Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up

• Published in: Medicine (Baltimore) Vol. 96; no. 39; p. e8133
• Main Authors: Türk Börü, Ülkü, Duman, Arda, Bölük, Cem, Coşkun Duman, Sanem, Taşdemir, Mustafa
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health 01.09.2017
• Subjects: Adult; Aged; Botulinum Toxins, Type A - administration & dosage; Clinical Trial/Experimental Study; Female; Follow-Up Studies; Humans; Injections; Male; Mandibular Nerve; Maxillary Nerve; Middle Aged; Neuromuscular Agents - administration & dosage; Pain Measurement; Recurrence; Treatment Outcome; Trigeminal Neuralgia - drug therapy

Botulinum toxin type-A (BTX-A) has been successfully utilized to treat trigeminal neuralgia. In this study, through the use of a new technique, the efficacy of the injection of BTX-A to the maxillary and mandibular nerves was evaluated. A total of 27 patients were injected with 100 Units of BTX-A to...